Whitehawk Therapeutics (WHWK) Current Assets (2010 - 2026)
Whitehawk Therapeutics (WHWK) reported Current Assets of $125.5 million for Q1 2026, down 46.03% year-over-year from $232.6 million in Q1 2025, and down 15.75% on a QoQ basis from $149.0 million in Q4 2025.
Whitehawk Therapeutics (WHWK) has 15 years of Current Assets data on file, last reported at $125.5 million in Q1 2026.
- Quarterly Current Assets fell 46.03% year-over-year to $125.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $125.5 million (down 46.03% YoY) and the FY2025 annual result came in at $149.0 million, up 143.14% from the prior year.
- Current Assets slipped to $125.5 million in Q1 2026 per WHWK's latest filing, from $149.0 million in the prior quarter.
- Across five years, Current Assets topped out at $232.6 million in Q1 2025 and bottomed at $61.3 million in Q4 2024.
- The 5-year median for Current Assets is $135.6 million (2022), against an average of $140.1 million.
- The widest annual swing landed in 2022, when Current Assets jumped 232.49%; it then tumbled 50.81% in 2024.
- Tracing WHWK's Current Assets over 5 years: stood at $180.0 million in 2022, then slumped by 30.8% to $124.6 million in 2023, then slumped by 50.81% to $61.3 million in 2024, then jumped by 143.14% to $149.0 million in 2025, then declined by 15.75% to $125.5 million in 2026.
- Per Business Quant, the three latest WHWK Current Assets figures stand at $125.5 million (Q1 2026), $149.0 million (Q4 2025), and $165.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 10.37 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 37.31 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.25 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 73.04 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 3.59 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 11.73 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 18.21 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 4.22 Bn |
| 10 | Whitehawk Therapeutics | 312.26 Mn | 189.22 Mn | - | 125.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 125.55 Mn |
| Dec 31, 2025 | 149.01 Mn |
| Sep 30, 2025 | 165.04 Mn |
| Jun 30, 2025 | 178.67 Mn |
| Mar 31, 2025 | 232.61 Mn |
| Dec 31, 2024 | 61.29 Mn |
| Sep 30, 2024 | 77.32 Mn |
| Jun 30, 2024 | 93.01 Mn |
| Mar 31, 2024 | 102.57 Mn |
| Dec 31, 2023 | 124.59 Mn |
| Sep 30, 2023 | 132.88 Mn |
| Jun 30, 2023 | 144.92 Mn |
| Mar 31, 2023 | 164.93 Mn |
| Dec 31, 2022 | 180.03 Mn |
| Sep 30, 2022 | 189.86 Mn |
| Jun 30, 2022 | 124.34 Mn |
| Mar 31, 2022 | 135.62 Mn |
| Dec 31, 2021 | 151.27 Mn |
| Sep 30, 2021 | 162.02 Mn |
| Jun 30, 2021 | 37.39 Mn |
| Mar 31, 2021 | 41.00 Mn |
| Dec 31, 2020 | 18.69 Mn |
| Sep 30, 2020 | 49.58 Mn |
| Jun 30, 2020 | 45.43 Mn |
| Mar 31, 2020 | 35.39 Mn |
| Dec 31, 2019 | 39.57 Mn |
| Sep 30, 2019 | 44.80 Mn |
| Jun 30, 2019 | 48.79 Mn |
| Mar 31, 2019 | 54.30 Mn |
| Dec 31, 2018 | 63.98 Mn |
| Sep 30, 2018 | 70.04 Mn |
| Jun 30, 2018 | 69.43 Mn |
| Mar 31, 2018 | 14.61 Mn |
| Dec 31, 2017 | 20.90 Mn |
| Sep 30, 2017 | 25.86 Mn |
| Jun 30, 2017 | 29.64 Mn |
| Mar 31, 2017 | 36.12 Mn |
| Dec 31, 2016 | 2.23 Mn |
| Mar 31, 2013 | 3,831.00 |
| Dec 31, 2012 | 8,107.00 |
| Sep 30, 2012 | 11,266.00 |
| Jun 30, 2012 | 15,561.00 |
| Mar 31, 2012 | 24,223.00 |
| Dec 31, 2011 | 6,625.00 |
| Sep 30, 2011 | 10,505.00 |
| Jun 30, 2011 | 15,480.00 |
| Dec 31, 2010 | 29,398.00 |